Nav: Home

Skin cancer above the neck more likely to spread, research shows

October 10, 2019

(MADRID, 11 October, 2019) New results from a descriptive, 6-month clinical study suggest that malignant melanoma (MM) that develops on the neck has a higher chance of spreading beyond the skin compared with MM that develops below the neck. However, even though significantly more of these study patients had below neck MM tumors at an advanced disease stage, none of them were found to have distant metastases, in which MM spreads to other distant parts of the body. Furthermore, only one of these below neck MM patients was diagnosed with positive lymph nodes. The study findings were presented today at the 28th EADV Congress in Madrid, Spain.

Forty-five patients with new diagnoses of MM were investigated over a period of 6 months and were divided into two groups of patients, with above neck MM and below neck MM. The aim of the study was to see which types of MM were more likely to metastasize (spread) in terms of location.

Researchers used computer tomography (CT) staging to determine the existence and spread of the cancer. Patients who had stage T2a or more disease were also offered a sentinel lymph node biopsy (SLNB) to further investigate the extent of the disease.

Results revealed that out of the 37 below neck MM patients, none of them had distant metastases and only one had positive nodes (2.7%). Out of the 8 above neck MM patients, two had positive nodes and distant metastases (25%). Therefore, the study showed that above neck MM has a higher chance of spreading beyond the skin in comparison with below neck MM.

The most dangerous skin cancer

Malignant melanoma is the most dangerous type of skin cancer and is becoming progressively more common, especially in younger populations.1 Once MM has spread deeper into the skin or other parts of the body, it becomes more difficult to treat and can be deadly. In addition, melanomas often have mutations in the BRAF V600 gene. These changes affect the production of the BRAF protein and make cells grow faster.

"A mutation in the gene encoding BRAF has been well demonstrated to occur in association with malignant melanoma, and this has revolutionized further management in patients with advanced disease. In this study, we have reviewed new MM diagnoses to see which ones are more likely to metastasize in terms of location. Understanding more about these locations also may help to determine and manage a patient's survival," explained Dr Mohammed Al Abadie lead researcher of the study, who presented the results at the EADV conference.
-end-
Notes to Editors

A reference to the 28th EADV Congress must be included when communicating any information within this press release.

Contact:

For further information or to arrange an expert interview, please contact either:

Phoebe Deans - EADV Press Officer
phoebe@spinkhealth.com
+44 (0) 7732 499170
+44 (0) 1444 811099

Jamie Wilkes - EADV Press Officer
jamie@spinkhealth.com
+44 (0) 7732 499170
+44 (0) 1444 811099

Luke Paskins - EADV Press Officer
luke@spinkhealth.com
+44 (0) 1444 811099

About Dr Mohammed Al Abadie

Dr Mohammed Al Abadie is from the Royal Wolverhampton NHS Trust, New Cross Hospital Department of Dermatology, United Kingdom

About EADV:

Founded in 1987, EADV is a non-profit organisation whose vision is to be the premier European Dermato-Venereology Society. The Academy counts over 7,000 members from 100 countries, providing a valuable service for every type of dermato-venereologist professional. EADV are dedicated to advancing patient care, education and research by providing a unique platform to bring people together and share ideas.

The EADV Congress takes place every year and attracts over 13,000 attendees. Boasting an exceptional Scientific Programme and educational experience with more than 180 sessions across various tracks, expert speakers will discuss the latest advances and information on trending topics in dermatology.

Find out more via the EADV website: https://www.eadv.org/

References:

1. Swetter, SM., Clarke, CA., Hurley S. Continuous increase in melanoma incidence across all socioeconomic status groups in California. J Invest dermatol. 2017. Nov; 137(11): 2282-2290.

2. Yuxen, L., Saeed Sheikh, M., Melanoma molecular pathogenesis and therapeutic management. Mol Cell Pharmacol. 2014; 6(3): 228.

Spink Health

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.